Pabatang, Zedric Angelo .
HRN: 21-82-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2022
CEFUROXIME 750MG (VIAL)
08/31/2022
09/06/2022
IV
200mg
Q8
Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes